Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

  1. Ginde, A.A.
  2. Paredes, R.
  3. Murray, T.A.
  4. Engen, N.
  5. Grandits, G.
  6. Vekstein, A.
  7. Ivey, N.
  8. Mourad, A.
  9. Sandkovsky, U.
  10. Gottlieb, R.L.
  11. Berhe, M.
  12. Jain, M.K.
  13. Marines-Price, R.
  14. Agbor Agbor, B.T.
  15. Mateu, L.
  16. España-Cueto, S.
  17. Lladós, G.
  18. Mylonakis, E.
  19. Rogers, R.
  20. Shehadeh, F.
  21. Filbin, M.R.
  22. Hibbert, K.A.
  23. Kim, K.
  24. Tran, T.
  25. Morris, P.E.
  26. Cassity, E.P.
  27. Trautner, B.
  28. Pandit, L.M.
  29. Knowlton, K.U.
  30. Leither, L.
  31. Matthay, M.A.
  32. Rogers, A.J.
  33. Drake, W.
  34. Jones, B.
  35. Poulakou, G.
  36. Syrigos, K.N.
  37. Fernández-Cruz, E.
  38. Natale, M.D.
  39. Almasri, E.
  40. Balerdi-Sarasola, L.
  41. Bhagani, S.R.
  42. Boyle, K.L.
  43. Casey, J.D.
  44. Chen, P.
  45. Douin, D.J.
  46. Files, D.C.
  47. Günthard, H.F.
  48. Hite, R.D.
  49. Hyzy, R.C.
  50. Khan, A.
  51. Kibirige, M.
  52. Kidega, R.
  53. Kiweewa, F.
  54. Jensen, J.-U.
  55. Leshnower, B.G.
  56. Lutaakome, J.K.
  57. Manian, P.
  58. Menon, V.
  59. Morales-Rull, J.L.
  60. O'Mahony, D.S.
  61. Overcash, J.S.
  62. Ramachandruni, S.
  63. Steingrub, J.S.
  64. Taha, H.S.
  65. Waters, M.
  66. Young, B.E.
  67. Phillips, A.N.
  68. Murray, D.D.
  69. Jensen, T.O.
  70. Padilla, M.L.
  71. Sahner, D.
  72. Shaw-Saliba, K.
  73. Dewar, R.L.
  74. Teitelbaum, M.
  75. Natarajan, V.
  76. Rehman, M.T.
  77. Pett, S.
  78. Hudson, F.
  79. Touloumi, G.
  80. Brown, S.M.
  81. Self, W.H.
  82. Chang, C.C.
  83. Sánchez, A.
  84. Weintrob, A.C.
  85. Hatlen, T.
  86. Grund, B.
  87. Sharma, S.
  88. Reilly, C.S.
  89. Garbes, P.
  90. Esser, M.T.
  91. Templeton, A.
  92. Babiker, A.G.
  93. Davey, V.J.
  94. Gelijns, A.C.
  95. Higgs, E.S.
  96. Kan, V.
  97. Matthews, G.
  98. Thompson, B.T.
  99. Neaton, J.D.
  100. Lane, H.C.
  101. Lundgren, J.D.
  102. Montrer des auteurs +
Revue:
The Lancet Respiratory Medicine

ISSN: 2213-2619,  2213-2600

Année de publication: 2022

Volumen: 10

Número: 10

Pages: 972-984

Type: Article

DOI: 10.1016/S2213-2600(22)00215-6 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus